Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Marpai, Inc.MRAI · Entity 7110 | Chief Operating Officer | November 07, 2025 | November 12, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Marpai, Inc.
Report date November 07, 2025 · Filed November 12, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectBy Dallas S. Scrip and Michelle R. Script Trust | 100,000 |
Reported balance
After 2025-11-07 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-11-07 · Grant · Acquired 100,000 · Balance 100,000 F1: On November 7, 2025, Marpai Inc. (the "Company") entered into a Securities Purchase Agreement for a private placement offering, in which the reporting person purchased 100,000 shares of common stock of the Company and common warrants to purchase up to 200,000 shares of common stock of the Company. The purchase price for each share of common stock and accompanying common warrant is $1.00. The common warrants have an exercise price of $1.00 per share, can be exercised immediately following the closing of the private placement offering and will be exercisable for three years following the date of issuance. F2: The securities are held by the Dallas S. Scrip and Michelle R. Script Trust, of which the reporting person and spouse are co-trustees and share investment and voting control. |
| Common Warrants to purchase Shares of Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2028-11-06 | IndirectBy Dallas S. Scrip and Michelle R. Script Trust | 200,000 |
Reported balance
After 2025-11-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-11-07 · Purchase · Acquired 200,000 · Balance 200,000 F1: On November 7, 2025, Marpai Inc. (the "Company") entered into a Securities Purchase Agreement for a private placement offering, in which the reporting person purchased 100,000 shares of common stock of the Company and common warrants to purchase up to 200,000 shares of common stock of the Company. The purchase price for each share of common stock and accompanying common warrant is $1.00. The common warrants have an exercise price of $1.00 per share, can be exercised immediately following the closing of the private placement offering and will be exercisable for three years following the date of issuance. F2: The securities are held by the Dallas S. Scrip and Michelle R. Script Trust, of which the reporting person and spouse are co-trustees and share investment and voting control. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 7, 2025, Marpai Inc. (the "Company") entered into a Securities Purchase Agreement for a private placement offering, in which the reporting person purchased 100,000 shares of common stock of the Company and common warrants to purchase up to 200,000 shares of common stock of the Company. The purchase price for each share of common stock and accompanying common warrant is $1.00. The common warrants have an exercise price of $1.00 per share, can be exercised immediately following the closing of the private placement offering and will be exercisable for three years following the date of issuance.
F2: The securities are held by the Dallas S. Scrip and Michelle R. Script Trust, of which the reporting person and spouse are co-trustees and share investment and voting control.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 07, 2025 Filed Nov 12, 2025 11:48 UTC | Marpai, Inc. MRAI · Entity 7110 | PurchaseCommon Warrants to purchase Shares of Common Stock · Derivative | 200,000 | Not disclosed Strike: $1.00 | Not disclosed |
DisclosureSEC source: 0001213900-25-108614 · ownership.xml · derivative · entry 2 Scrip Dallas · CIK 0002069643 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Dallas S. Scrip and Michelle R. Script Trust Disclosed balance after: 200,000 Underlying: Shares of Common Stock · 200,000 shares Expires 2028-11-06 F1 · price: On November 7, 2025, Marpai Inc. (the "Company") entered into a Securities Purchase Agreement for a private placement offering, in which the reporting person purchased 100,000 shares of common stock of the Company and common warrants to purchase up to 200,000 shares of common stock of the Company. The purchase price for each share of common stock and accompanying common warrant is $1.00. The common warrants have an exercise price of $1.00 per share, can be exercised immediately following the closing of the private placement offering and will be exercisable for three years following the date of issuance. F2 · ownership.nature: The securities are held by the Dallas S. Scrip and Michelle R. Script Trust, of which the reporting person and spouse are co-trustees and share investment and voting control. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 11:48 UTC | Marpai, Inc. MRAI · Entity 7110 | GrantClass A Common Stock | 100,000 | $1.00 | $100,000.00 |
DisclosureSEC source: 0001213900-25-108614 · ownership.xml · nonDerivative · entry 1 Scrip Dallas · CIK 0002069643 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Indirect · By Dallas S. Scrip and Michelle R. Script Trust Disclosed balance after: 100,000 F1 · shares: On November 7, 2025, Marpai Inc. (the "Company") entered into a Securities Purchase Agreement for a private placement offering, in which the reporting person purchased 100,000 shares of common stock of the Company and common warrants to purchase up to 200,000 shares of common stock of the Company. The purchase price for each share of common stock and accompanying common warrant is $1.00. The common warrants have an exercise price of $1.00 per share, can be exercised immediately following the closing of the private placement offering and will be exercisable for three years following the date of issuance. F2 · ownership.nature: The securities are held by the Dallas S. Scrip and Michelle R. Script Trust, of which the reporting person and spouse are co-trustees and share investment and voting control. Read SEC document |
| June 09, 2025 Filed Jun 12, 2025 20:17 UTC | Marpai, Inc. MRAI · Entity 7110 | GrantClass A Common Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-053834 · ownership.xml · nonDerivative · entry 1 Scrip Dallas · CIK 0002069643 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 300,000 F1 · shares: The RSUs vest according to the following schedule: 100,000 RSUs vest on the first anniversary of the grant, 100,000 RSU vest on the second anniversary of the grant, and 100,000 RSUS vest immediately upon the Marpai Inc. reaching $5 million in unadjusted EBITDA for a full fiscal year in which Mr. Scrip is employed by the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.